Home Statistical Dictionary Double-Blind Study
Double-Blind Study
A study design in which neither the participants nor the researchers assessing outcomes know who received the treatment versus the control, guarding simultaneously against placebo effects on participants and assessment or expectation bias among researchers.
In Plain English
A double-blind study takes the concept of blinding and applies it twice over: participants don't know whether they got the actual treatment or the control/placebo (guarding against the placebo effect, where just believing you got treated can genuinely change outcomes), and separately, the researchers or clinicians assessing outcomes also don't know who got what (guarding against the researchers unconsciously scoring or interpreting results differently based on their expectations about which group should do better). Double-blinding is generally considered stronger evidence than single-blinding alone, since it removes two distinct, independent sources of bias, participant expectation and assessor expectation, at the same time.
Definition
A double-blind study conceals treatment group assignment from two separate parties simultaneously, the study participants themselves (who do not know whether they are receiving the active treatment or a control/placebo) and the researchers, clinicians, or outcome assessors who interact with participants or evaluate their outcomes (who also do not know each participant's group assignment). Double-blinding addresses two distinct sources of bias at once, the placebo effect and participant expectation effects on the subjective or self-reported side, and observer/assessor expectation bias (unconsciously scoring, coding, or interpreting outcomes differently based on knowledge of group assignment) on the researcher side, this second protection is what distinguishes double-blinding from single-blinding, in which only participants (and not assessors) are blinded, leaving assessor expectation bias unaddressed; double-blinding is not always feasible, some interventions have obvious, unmaskable effects (surgery versus no surgery, a drug with a very distinctive side effect), in which case alternative safeguards like blinded outcome assessment by an independent evaluator not otherwise involved in delivering the treatment are used instead.
Properties
- Double-blinding protects against two genuinely independent sources of bias simultaneously, this is the key distinction from single-blinding, which only protects against participant-side effects (the placebo effect) and leaves the researcher or assessor free, even if unintentionally, to interpret or score outcomes in a way that favors their expectations about the treatment's effectiveness.
- When an intervention cannot be practically or ethically masked from participants or clinicians delivering it (a surgical procedure versus no surgery, for instance), blinded outcome assessment, having an independent evaluator who did not deliver the treatment and does not know group assignment assess the outcomes, is a common partial substitute that preserves some of double-blinding's protection against assessment bias.
- Double-blind randomized controlled trials are widely regarded as the strongest standard evidentiary design in clinical and pharmaceutical research specifically because they combine two of the most powerful available protections against bias, randomization (protecting against confounding) and double-blinding (protecting against both placebo and assessment effects), in a single study.
At a Glance